HPGC Renmintongtai Pharmaceutical (SHSE:600829) Days Sales Outstanding : 146.05 (As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Days Sales Outstanding?

HPGC Renmintongtai Pharmaceutical's average Accounts Receivable for the three months ended in Sep. 2024 was ¥4,310 Mil. HPGC Renmintongtai Pharmaceutical's Revenue for the three months ended in Sep. 2024 was ¥2,693 Mil. Hence, HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding for the three months ended in Sep. 2024 was 146.05.

The historical rank and industry rank for HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding or its related term are showing as below:

SHSE:600829' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.55 Med: 127.99 Max: 153.22
Current: 153.22

During the past 13 years, HPGC Renmintongtai Pharmaceutical's highest Days Sales Outstanding was 153.22. The lowest was 43.55. And the median was 127.99.

SHSE:600829's Days Sales Outstanding is ranked worse than
90.21% of 970 companies
in the Drug Manufacturers industry
Industry Median: 71.605 vs SHSE:600829: 153.22

HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding declined from Sep. 2023 (154.13) to Sep. 2024 (146.05).

HPGC Renmintongtai Pharmaceutical Days Sales Outstanding Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Days Sales Outstanding Chart

HPGC Renmintongtai Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

121.65

151.71

143.25

147.04

142.12

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															154.13	151.41	150.03	164.37	146.05

Competitive Comparison of HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding falls into.

HPGC Renmintongtai Pharmaceutical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3915.688	+	4175.243)	/	2 )	/	10389.98	*	365
=	4045.4655					/	10389.98	*	365
=	142.12

HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (4233.405	+	4385.895)	/	2 )	/	2692.556	*	365 / 4
=	4309.65					/	2692.556	*	365 / 4
=	146.05

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

HPGC Renmintongtai Pharmaceutical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi	senior management
Zhang Li Jun	Director

HPGC Renmintongtai Pharmaceutical Headlines

No Headlines